17 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/17/3043688/0/en/Lirum-Therapeutics-Announces-Debut-of-LX-101-Results-in-Thyroid-Eye-Disease-Selected-for-Presentation-at-the-2025-NANOS-Annual-Meeting.html
25 Jul 2024
// BUSINESSWIRE
23 Jul 2024
// BUSINESSWIRE
03 Jun 2024
// BUSINESSWIRE
03 Jun 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/06/03/2892199/0/en/Entera-Bio-Reports-Phase-1-Clinical-Data-of-First-in-Class-Oral-PTH-1-34-Peptide-Candidate-EB612-for-Patients-with-Hypoparathyroidism-at-ENDO-2024.html
03 Jul 2019
// FDA
https://www.pharmacompass.com/pdf/news/izeen-pharma-inc-receives-fda-warning-letter-1562148790.pdf